Nanoparticle-based materials in anticancer drug delivery: Current and future prospects

Area of Science:

• Oncology
• Nanotechnology
• Materials Science

Background:

• Chemotherapy is a common cancer treatment but causes side effects on healthy cells.
• Nanocarriers are being developed to improve targeted drug delivery to cancer cells.
• Encapsulating drugs in nanocarriers is a safer and more effective alternative to free-form drug delivery.

Purpose of the Study:

• To review various nanocarriers used for cancer drug delivery.
• To discuss the synthesis, applications, advantages, and disadvantages of these nanomaterials.
• To explore future opportunities and challenges for clinical translation.

Main Methods:

• Literature review of nanocarriers for cancer drug delivery.
• Detailed discussion of synthesis, applications, and properties of nanocarriers.
• Analysis of previous studies and clinical translation potential.

Main Results:

• Various nanocarriers like liposomes, polymeric micelles, dendrimers, and nanoparticles show promise.
• Nanocarrier-based drug delivery enhances efficacy and reduces toxicity compared to conventional chemotherapy.
• Significant research indicates improved cancer targeting and therapeutic outcomes.

Conclusions:

• Nanocarriers represent a significant advancement in cancer therapy, offering improved drug delivery and reduced side effects.
• Further research and development are crucial for overcoming challenges in clinical translation.
• The reviewed nanocarriers hold substantial potential for revolutionizing cancer treatment strategies.